Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Natera's chief legal officer executes stock transactions

Published 24/04/2024, 02:42

In recent market activity, Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, has engaged in multiple transactions involving the company's stock. On April 20 and 21, Rabinowitz acquired a total of 1,500 shares of Natera's common stock through the vesting of restricted stock units (RSUs). These transactions did not involve any monetary exchange as they were related to the vesting of previously granted RSUs.

However, on April 23, Rabinowitz sold 787 shares of common stock at an average price of $91.3792, totaling approximately $71,915. The sale was made to cover tax withholding obligations related to the vesting of the RSUs, in accordance with pre-determined written instructions compliant with Rule 10b5-1(c) under the Exchange Act. The instructions were part of the stock unit agreements dated January 22, 2021, and January 28, 2022.

Following these transactions, Rabinowitz's direct ownership in Natera stands at 205,552 shares of common stock. Additionally, post-transaction, he holds 5,924 shares in the form of RSUs, which will continue to vest over a four-year period with 25% having vested on January 20, 2023, and January 21, 2022, respectively, and the remainder vesting in equal quarterly installments.

Investors often monitor insider transactions as they can provide insights into executives' perspectives on the company's value and future performance. Natera's shares are publicly traded, and these transactions are reported in compliance with SEC regulations.

InvestingPro Insights

Amidst the insider transactions at Natera, Inc. (NASDAQ:NTRA), the market has also witnessed significant movements in the company's stock metrics. Natera's market capitalization is currently at $10.99 billion, reflecting the company's substantial presence in the genetic testing and diagnostics market. Despite the company not being profitable over the last twelve months, as indicated by a negative P/E ratio of -25.98, investors have seen a high return over the past year, with a 67.19% one-year price total return. This suggests strong investor confidence in Natera's growth potential and market position.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Tips highlight that Natera operates with a moderate level of debt and that its liquid assets exceed short-term obligations, providing financial stability. In addition, Natera is trading at a high Price/Book multiple of 14.76, which could indicate that the market values the company's assets and future growth prospects highly. With a notable 117.23% six-month price total return, the company's stock performance has been robust, reflecting positive investor sentiment. For those interested in deeper analysis, there are additional InvestingPro Tips available for Natera at https://www.investing.com/pro/NTRA, including insights on revenue growth and profitability.

For readers looking to explore these insights in more depth, InvestingPro offers a comprehensive suite of analytical tools and data. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain access to an extended list of 11 InvestingPro Tips that can further inform investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.